Halo Diagnostics Logo

A Pioneer in Minimally Invasive Prostate Cancer Treatment

Watch the video to hear our story

Preserving Quality of Life with Minimally Invasive Treatment Options

1 in 8 men will receive a prostate cancer diagnosis this year. Thousands will be told they have limited options, and that is not true.

HALO Diagnostics has been a pioneer in advancing minimally invasive prostate cancer treatment with reduced side effects. HALO provides a treatment pathway personalized for each individual prostate cancer or BPH diagnosis. Treatment options include:
  • mpMRI prostate screenings to identify areas of suspicious tissue before an invasive biopsy.
  • The HALO Diagnostics ensemble approach of mpMRI + PSAD + ExoDx misses 0% of clinically significant prostate cancer 13.5% of unnecessary biopsies are completely avoided.
  • HALO offers two focal therapeutic treatment options:
    • Laser Focal Therapy (LFT)
    • TULSA-PRO®
MRI-guided Laser Focal Therapy showed a better safety profile than standard treatments for patients with localized prostate cancer. (Source: Urology Times 2020)

Call 760-718-6353 or email us today!

Call 760-718-6353 to schedule your complimentary consultation with a HALO Diagnostics expert today or complete the form below.

We provide rapid, precise, and actionable results that create life-changing and life-saving individualized plans for patients.

Precision Diagnostics

Saving lives with early detection and personalized care.

Breast Health

Empowering women’s health through precision diagnostics.

Prostate Health

Early detection saves lives. HALO is setting the new standard for prostate care.